Home » Topics » Regulatory » Patents

Patents
RSS

Anti-H. pylori cephems in development at Takeda

Nov. 19, 1998

Endothelin antagonists a focus of R&D at Merck KGaA

Nov. 19, 1998

Potent and selective 5-HT1A/5-HT1B/5-HT1D receptor antagonists discovered at Pierre Fabre

Nov. 18, 1998

New thiazolidinediones for diabetes reported in patent literature by Boehringer Mannheim

Nov. 18, 1998

Synthelabo discloses orally active human thrombin inhibitors

Nov. 18, 1998

5-HT antagonists in development at Synthelabo for cardiovascular and other disorders

Nov. 18, 1998

Synthesis and use of novel ET-antagonist series disclosed by Merck KGaA

Nov. 18, 1998

Series of nNOS inhibitors patented by Mitsui

Nov. 17, 1998

Teijin's new vitamin D derivatives induce cell differentiation

Nov. 17, 1998

Potent and selective nicotinic acetylcholine receptor ligands prepared at Synthelabo

Nov. 17, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...